Publications

Found 21 results

]

Filters: Author is Lyden, David [Clear All Filters]

2020

Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F et al.. 2020. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.. Cell Stem Cell. 27(1):125-136.e7.

2019

Rodrigues G, Hoshino A, Kenific CM, Matei IR, Steiner L, Freitas D, Kim HSang, Oxley PR, Scandariato I, Casanova-Salas I et al.. 2019. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.. Nat Cell Biol. 21(11):1403-1412.

2010

James D, Nam H-song, Seandel M, Nolan D, Janovitz T, Tomishima M, Studer L, Lee G, Lyden D, Benezra R et al.. 2010. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent.. Nat Biotechnol. 28(2):161-6.

Ding B-S, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D et al.. 2010. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration.. Nature. 468(7321):310-5.

2009

Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, Kaplan RN, Rafii S, Rivella S, Lyden D. 2009. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis.. PLoS One. 4(11):e7955.

2008

Rafii S, Lyden D. 2008. Cancer. A few to flip the angiogenic switch.. Science. 319(5860):163-4.

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK et al.. 2008. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.. J Clin Invest. 118(6):2111-20.

Peinado H, Rafii S, Lyden D. 2008. Inflammation joins the "niche".. Cancer Cell. 14(5):347-9.

Wels J, Kaplan RN, Rafii S, Lyden D. 2008. Migratory neighbors and distant invaders: tumor-associated niche cells.. Genes Dev. 22(5):559-74.

2006

Jin DK, Shido K, Kopp H-G, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B et al.. 2006. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.. Nat Med. 12(5):557-67.

Kaplan RN, Rafii S, Lyden D. 2006. Preparing the "soil": the premetastatic niche.. Cancer Res. 66(23):11089-93.

2005

Shmelkov SV, St Clair R, Lyden D, Rafii S. 2005. AC133/CD133/Prominin-1.. Int J Biochem Cell Biol. 37(4):715-9.

Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA et al.. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.. Nature. 438(7069):820-7.

2004

Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE et al.. 2004. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.. Nat Med. 10(1):64-71.

2003

2002

Rafii S, Meeus S, Dias S, Hattori K, Heissig B, Shmelkov S, Rafii D, Lyden D. 2002. Contribution of marrow-derived progenitors to vascular and cardiac regeneration.. Semin Cell Dev Biol. 13(1):61-7.

Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L et al.. 2002. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.. Nat Med. 8(8):841-9.

Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MAS et al.. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.. Cell. 109(5):625-37.

Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. 2002. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer. 2(11):826-35.